{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:53:54Z","timestamp":1788951234341,"version":"build-2803163510"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81771741"],"award-info":[{"award-number":["81771741"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Distinguished Professor at Educational Department of Liaoning Province","award":["[2014]187"],"award-info":[{"award-number":["[2014]187"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Global Coronavir us disease 2019 (COVID-19) vaccination efforts are being intensified to combat the pandemic. As the frequency of immunization against COVID-19 has increased, some adverse effects related to vaccination have emerged. Within this context, this article reviewed 62 Graves\u2019 disease (GD) cases following COVID-19 vaccination, to probe the potential association between the vaccination and the onset of GD. A comprehensive search of the PubMed, Web of Science, and Scopus databases was conducted to collect GD cases following COVID-19 vaccination up to June 7, 2023. Among the 62 GD cases included in this review, there were 33 (53.2%) new-onset GD and 10 (16.1%) relapsed GD patients following mRNA vaccination, 14 (22.6%) new-onset GD and 4 (6.5%) relapsed GD patients following viral vector vaccination, and 1 (1.6%) relapsed GD patients following inactivated vaccination. Median durations to symptoms onset for new-onset and relapsed GD were 12 (range: 1\u201360) and 21 (range: 5\u201330) days following mRNA vaccination, while 7 (range: 1\u201328) and 14 (range: 10\u201314) days following viral vector vaccination, respectively. While the definitive pathogenesis of GD following COVID-19 vaccination remains unclear, it might be associated with cross-immune responses triggered by molecular mimicry, and an adjuvant-induced autoimmune\/inflammatory syndrome. However, due to the limited number of observed GD cases following COVID-19 vaccination and the lack of systematic experimental studies, a causal relationship between COVID-19 vaccination and the onset of GD has not been definitively confirmed. It should be highlighted that most of GD patients following COVID-19 vaccination experienced positive outcomes after treatment. In the broader context of ending the COVID-19 pandemic and reducing mortality rates, the benefits of COVID-19 vaccination significantly outweigh mild risks such as treatable GD. Adherence to the COVID-19 vaccination schedule is therefore imperative in effectively managing the pandemic.<\/jats:p>","DOI":"10.1186\/s40001-023-01210-7","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T07:02:36Z","timestamp":1689231756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["New-onset and relapsed Graves\u2019 disease following COVID-19 vaccination: a\u00a0comprehensive review of reported cases"],"prefix":"10.1186","volume":"28","author":[{"given":"Kan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3681-4095","authenticated-orcid":false,"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"issue":"3","key":"1210_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141\u201354. https:\/\/doi.org\/10.1038\/s41579-020-00459-7.","journal-title":"Nat Rev Microbiol"},{"key":"1210_CR2","unstructured":"World Health Organization (WHO). WHO Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int\/. Accessed 7 June 2023."},{"issue":"2","key":"1210_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1152\/physiol.00033.2021","volume":"37","author":"S Upadhya","year":"2022","unstructured":"Upadhya S, Rehman J, Malik AB, Chen S. Mechanisms of lung injury induced by SARS-CoV-2 infection. Physiology (Bethesda). 2022;37(2):88\u2013100. https:\/\/doi.org\/10.1152\/physiol.00033.2021.","journal-title":"Physiology (Bethesda)"},{"key":"1210_CR4","doi-asserted-by":"publisher","first-page":"e928996","DOI":"10.12659\/MSM.928996","volume":"26","author":"F Wang","year":"2020","unstructured":"Wang F, Kream RM, Stefano GB. Long-term respiratory and neurological sequelae of COVID-19. Med Sci Monit. 2020;26:e928996. https:\/\/doi.org\/10.12659\/MSM.928996.","journal-title":"Med Sci Monit."},{"issue":"7","key":"1210_CR5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s40618-020-01276-8","volume":"43","author":"R Pal","year":"2020","unstructured":"Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43(7):1027\u201331. https:\/\/doi.org\/10.1007\/s40618-020-01276-8.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1210_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3803\/EnM.2020.35.2.197","volume":"35","author":"EJ Rhee","year":"2020","unstructured":"Rhee EJ, Kim JH, Moon SJ, Lee WY. Encountering COVID-19 as endocrinologists. Endocrinol Metab (Seoul). 2020;35(2):197\u2013205. https:\/\/doi.org\/10.3803\/EnM.2020.35.2.197.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"9","key":"1210_CR7","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s40618-021-01576-7","volume":"44","author":"G Lanzolla","year":"2021","unstructured":"Lanzolla G, Marcocci C, Marino M. Graves\u2019 disease and Graves\u2019 orbitopathy following COVID-19. J Endocrinol Invest. 2021;44(9):2011\u20132. https:\/\/doi.org\/10.1007\/s40618-021-01576-7.","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"1210_CR8","doi-asserted-by":"publisher","first-page":"dgaa276","DOI":"10.1210\/clinem\/dgaa276","volume":"105","author":"A Brancatella","year":"2020","unstructured":"Brancatella A, Ricci D, Viola N, Sgro D, Santini F, Latrofa F. Subacute thyroiditis after sars-COV-2 infection. J Clin Endocrinol Metab. 2020;105(7):dgaa276. https:\/\/doi.org\/10.1210\/clinem\/dgaa276.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1210_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/01455613211012114","volume":"101","author":"A Seyed Resuli","year":"2022","unstructured":"Seyed Resuli A, Bezgal M. Subacute thyroiditis in COVID-19 patients. Ear Nose Throat J. 2022;101(8):501\u20135. https:\/\/doi.org\/10.1177\/01455613211012114.","journal-title":"Ear Nose Throat J"},{"issue":"7","key":"1210_CR10","doi-asserted-by":"publisher","first-page":"16497","DOI":"10.7759\/cureus.16497","volume":"13","author":"MS Alshamam","year":"2021","unstructured":"Alshamam MS, Nso N, Idrees Z, Iqbal S, Ghernautan V, Sumbly V, et al. New-onset diabetes in the setting of beta-cell dysfunction in a young patient with COVID-19 infection. Cureus. 2021;13(7):16497. https:\/\/doi.org\/10.7759\/cureus.16497.","journal-title":"Cureus"},{"issue":"1","key":"1210_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s44194-022-00006-x","volume":"1","author":"JK Yang","year":"2022","unstructured":"Yang JK, Zhao MM, Jin JM, Liu S, Bai P, He W, et al. New-onset COVID-19-related diabetes: an early indicator of multi-organ injury and mortally of SARS-CoV-2 infection. Curr Med (Cham). 2022;1(1):6. https:\/\/doi.org\/10.1007\/s44194-022-00006-x.","journal-title":"Curr Med (Cham)"},{"issue":"10","key":"1210_CR12","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s40618-020-01366-7","volume":"43","author":"M Mateu-Salat","year":"2020","unstructured":"Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves\u2019 disease after COVID-19. J Endocrinol Invest. 2020;43(10):1527\u20138. https:\/\/doi.org\/10.1007\/s40618-020-01366-7.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1210_CR13","first-page":"e22260","volume":"14","author":"H Ghareebian","year":"2022","unstructured":"Ghareebian H, Mariash C. COVID-19-induced Graves\u2019 disease. Cureus. 2022;14(2):e22260.","journal-title":"Cureus"},{"issue":"6","key":"1210_CR14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.rceng.2021.01.002","volume":"221","author":"L-F de la Higuera","year":"2021","unstructured":"de la Higuera L-F, Perdomo CM, Galofre JC. Subacute thyroiditis following COVID-19 infection. Rev Clin Esp (Barc). 2021;221(6):370\u20132. https:\/\/doi.org\/10.1016\/j.rceng.2021.01.002.","journal-title":"Rev Clin Esp (Barc)"},{"key":"1210_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","volume":"114","author":"C Zheng","year":"2022","unstructured":"Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect Dis. 2022;114:252\u201360. https:\/\/doi.org\/10.1016\/j.ijid.2021.11.009.","journal-title":"Int J Infect Dis"},{"key":"1210_CR16","unstructured":"Our World in Data. Coronavirus (COVID-19) Vaccinations. https:\/\/ourworldindata.org\/covid-vaccinations. Accessed 7 June 2023."},{"issue":"3","key":"1210_CR17","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.26355\/eurrev_202102_24877","volume":"25","author":"SA Meo","year":"2021","unstructured":"Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna Vaccines. Eur Rev Med Pharmacol Sci. 2021;25(3):1663\u20139. https:\/\/doi.org\/10.26355\/eurrev_202102_24877.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"1210_CR18","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1002\/jmv.27214","volume":"93","author":"QA Al Khames Aga","year":"2021","unstructured":"Al Khames Aga QA, Alkhaffaf WH, Hatem TH, Nassir KF, Batineh Y, Dahham AT, et al. Safety of COVID-19 vaccines. J Med Virol. 2021;93(12):6588\u201394. https:\/\/doi.org\/10.1002\/jmv.27214.","journal-title":"J Med Virol"},{"issue":"10","key":"1210_CR19","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1001\/jamacardio.2021.2833","volume":"6","author":"J Montgomery","year":"2021","unstructured":"Montgomery J, Ryan M, Engler R, Hoffman D, McClenathan B, Collins L, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. 2021;6(10):1202\u20136. https:\/\/doi.org\/10.1001\/jamacardio.2021.2833.","journal-title":"JAMA Cardiol"},{"issue":"4","key":"1210_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1182\/blood.2021012152","volume":"138","author":"GM Arepally","year":"2021","unstructured":"Arepally GM, Ortel TL. Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know. Blood. 2021;138(4):293\u20138. https:\/\/doi.org\/10.1182\/blood.2021012152.","journal-title":"Blood"},{"issue":"11","key":"1210_CR21","doi-asserted-by":"publisher","first-page":"102941","DOI":"10.1016\/j.autrev.2021.102941","volume":"20","author":"F Elrashdy","year":"2021","unstructured":"Elrashdy F, Tambuwala MM, Hassan SS, Adadi P, Seyran M, Abd El-Aziz TM, et al. Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmun Rev. 2021;20(11):102941. https:\/\/doi.org\/10.1016\/j.autrev.2021.102941.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"1210_CR22","doi-asserted-by":"publisher","first-page":"102951","DOI":"10.1016\/j.autrev.2021.102951","volume":"20","author":"L Badier","year":"2021","unstructured":"Badier L, Toledano A, Porel T, Dumond S, Jouglen J, Sailler L, et al. IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19. Autoimmun Rev. 2021;20(11):102951. https:\/\/doi.org\/10.1016\/j.autrev.2021.102951.","journal-title":"Autoimmun Rev"},{"issue":"10047","key":"1210_CR23","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","volume":"388","author":"S De Leo","year":"2016","unstructured":"De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016;388(10047):906\u201318. https:\/\/doi.org\/10.1016\/S0140-6736(16)00278-6.","journal-title":"Lancet"},{"issue":"10","key":"1210_CR24","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343\u2013421. https:\/\/doi.org\/10.1089\/thy.2016.0229.","journal-title":"Thyroid"},{"issue":"2","key":"1210_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.23736\/S1824-4785.21.03344-6","volume":"65","author":"F D'Aurizio","year":"2021","unstructured":"D\u2019Aurizio F. The role of laboratory medicine in the diagnosis of the hyperthyroidism. Q J Nucl Med Mol Imag. 2021;65(2):91\u2013101. https:\/\/doi.org\/10.23736\/S1824-4785.21.03344-6.","journal-title":"Q J Nucl Med Mol Imag"},{"issue":"1","key":"1210_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0889-8529(05)70299-1","volume":"27","author":"B McIver","year":"1998","unstructured":"McIver B, Morris JC. The pathogenesis of Graves\u2019 disease. Endocrinol Metab Clin North Am. 1998;27(1):73\u201389. https:\/\/doi.org\/10.1016\/s0889-8529(05)70299-1.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1210_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.micpath.2018.01.004","volume":"116","author":"SK Shukla","year":"2018","unstructured":"Shukla SK, Singh G, Ahmad S, Pant P. Infections, genetic and environmental factors in pathogenesis of autoimmune thyroid diseases. Microb Pathog. 2018;116:279\u201388. https:\/\/doi.org\/10.1016\/j.micpath.2018.01.004.","journal-title":"Microb Pathog"},{"key":"1210_CR28","doi-asserted-by":"publisher","first-page":"794912","DOI":"10.3389\/fcell.2021.794912","volume":"9","author":"F Zhou","year":"2021","unstructured":"Zhou F, Wang X, Wang L, Sun X, Tan G, Wei W, et al. Genetics, epigenetics, cellular immunology, and gut microbiota: emerging links with Graves\u2019 disease. Front Cell Dev Biol. 2021;9:794912. https:\/\/doi.org\/10.3389\/fcell.2021.794912.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"1210_CR29","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/JME-20-0078","volume":"66","author":"E Razmara","year":"2021","unstructured":"Razmara E, Salehi M, Aslani S, Bitaraf A, Yousefi H, Colon JR, et al. Graves\u2019 disease: introducing new genetic and epigenetic contributors. J Mol Endocrinol. 2021;66(2):R33\u201355. https:\/\/doi.org\/10.1530\/JME-20-0078.","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"1210_CR30","doi-asserted-by":"publisher","first-page":"101387","DOI":"10.1016\/j.beem.2020.101387","volume":"34","author":"A Antonelli","year":"2020","unstructured":"Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, Ruffilli I, et al. Graves\u2019 disease: epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101387. https:\/\/doi.org\/10.1016\/j.beem.2020.101387.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"1210_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","volume":"6","author":"TF Davies","year":"2020","unstructured":"Davies TF, Andersen S, Latif R, Nagayama Y, Barbesino G, Brito M, et al. Graves\u2019 disease. Nat Rev Dis Primers. 2020;6(1):52. https:\/\/doi.org\/10.1038\/s41572-020-0184-y.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"1210_CR32","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s40618-022-01739-0","volume":"45","author":"B Pla Peris","year":"2022","unstructured":"Pla Peris B, Merchante Alfaro AA, Maravall Royo FJ, Abellan Galiana P, Perez Naranjo S, Gonzalez BM. Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion. J Endocrinol Invest. 2022;45(5):1071\u20137. https:\/\/doi.org\/10.1007\/s40618-022-01739-0.","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"1210_CR33","doi-asserted-by":"publisher","first-page":"e1823","DOI":"10.1210\/clinem\/dgac049","volume":"107","author":"SH Oguz","year":"2022","unstructured":"Oguz SH, Sendur SN, Iremli BG, Gurlek A, Erbas T, Unluturk U. SARS-CoV-2 vaccine-induced thyroiditis: safety of revaccinations and clinical follow-up. J Clin Endocrinol Metab. 2022;107(5):e1823\u201334. https:\/\/doi.org\/10.1210\/clinem\/dgac049.","journal-title":"J Clin Endocrinol Metab"},{"key":"1210_CR34","doi-asserted-by":"publisher","first-page":"102809","DOI":"10.1016\/j.jaut.2022.102809","volume":"128","author":"H Bostan","year":"2022","unstructured":"Bostan H, Ucan B, Kizilgul M, Calapkulu M, Hepsen S, Gul U, et al. Relapsed and newly diagnosed Graves\u2019 disease due to immunization against COVID-19: a case series and review of the literature. J Autoimmun. 2022;128:102809. https:\/\/doi.org\/10.1016\/j.jaut.2022.102809.","journal-title":"J Autoimmun"},{"issue":"6","key":"1210_CR35","doi-asserted-by":"publisher","first-page":"e2324","DOI":"10.1210\/clinem\/dgac119","volume":"107","author":"YJ Chee","year":"2022","unstructured":"Chee YJ, Liew H, Hoi WH, Lee Y, Lim B, Chin HX, et al. SARS-CoV-2 mRNA vaccination and graves\u2019 Disease: a report of 12 cases and review of the literature. J Clin Endocrinol Metab. 2022;107(6):e2324\u201330. https:\/\/doi.org\/10.1210\/clinem\/dgac119.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1210_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.47102\/annals-acadmedsg.2021398","volume":"51","author":"MWJ Chua","year":"2022","unstructured":"Chua MWJ. Graves\u2019 disease after COVID-19 vaccination. Ann Acad Med Singap. 2022;51(2):127\u20138. https:\/\/doi.org\/10.47102\/annals-acadmedsg.2021398.","journal-title":"Ann Acad Med Singap"},{"issue":"1","key":"1210_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s40618-021-01650-0","volume":"45","author":"G Zettinig","year":"2022","unstructured":"Zettinig G, Krebs M. Two further cases of Graves\u2019 disease following SARS-Cov-2 vaccination. J Endocrinol Invest. 2022;45(1):227\u20138. https:\/\/doi.org\/10.1007\/s40618-021-01650-0.","journal-title":"J Endocrinol Invest"},{"key":"1210_CR38","doi-asserted-by":"publisher","first-page":"102738","DOI":"10.1016\/j.jaut.2021.102738","volume":"125","author":"A Patrizio","year":"2021","unstructured":"Patrizio A, Ferrari SM, Antonelli A, Fallahi P. A case of Graves\u2019 disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination. J Autoimmun. 2021;125:102738. https:\/\/doi.org\/10.1016\/j.jaut.2021.102738.","journal-title":"J Autoimmun"},{"key":"1210_CR39","doi-asserted-by":"publisher","first-page":"232470962110633","DOI":"10.1177\/23247096211063356","volume":"9","author":"MA Weintraub","year":"2021","unstructured":"Weintraub MA, Ameer B, Sinha GN. Graves disease following the SARS-CoV-2 vaccine: case series. J Investig Med High Impact Case Rep. 2021;9:23247096211063356. https:\/\/doi.org\/10.1177\/23247096211063356.","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"9","key":"1210_CR40","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1089\/thy.2021.0142","volume":"31","author":"O Vera-Lastra","year":"2021","unstructured":"Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, Medina G, Sanchez Valadez TI, Jara LJ. Two cases of Graves\u2019 disease following SARS-CoV-2 vaccination: an autoimmune\/inflammatory syndrome induced by adjuvants. Thyroid. 2021;31(9):1436\u20139. https:\/\/doi.org\/10.1089\/thy.2021.0142.","journal-title":"Thyroid"},{"key":"1210_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246432","author":"TJ Goblirsch","year":"2021","unstructured":"Goblirsch TJ, Paulson AE, Tashko G, Mekonnen AJ. Graves\u2019 disease following administration of second dose of SARS-CoV-2 vaccine. BMJ Case Rep. 2021. https:\/\/doi.org\/10.1136\/bcr-2021-246432.","journal-title":"BMJ Case Rep"},{"issue":"4","key":"1210_CR42","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s40618-021-01707-0","volume":"45","author":"A Pujol","year":"2022","unstructured":"Pujol A, Gomez LA, Gallegos C, Nicolau J, Sanchis P, Gonzalez-Freire M, et al. Thyroid as a target of adjuvant autoimmunity\/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves\u2019 disease to silent thyroiditis. J Endocrinol Invest. 2022;45(4):875\u201382. https:\/\/doi.org\/10.1007\/s40618-021-01707-0.","journal-title":"J Endocrinol Invest"},{"key":"1210_CR43","doi-asserted-by":"publisher","first-page":"778964","DOI":"10.3389\/fpubh.2021.778964","volume":"9","author":"DTW Lui","year":"2021","unstructured":"Lui DTW, Lee KK, Lee CH, Lee ACH, Hung IFN, Tan KCB. Development of Graves\u2019 disease after SARS-CoV-2 mRNA vaccination: a case report and literature review. Front Public Health. 2021;9:778964. https:\/\/doi.org\/10.3389\/fpubh.2021.778964.","journal-title":"Front Public Health"},{"issue":"10","key":"1210_CR44","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.3390\/vaccines9101108","volume":"9","author":"K Yamamoto","year":"2021","unstructured":"Yamamoto K, Mashiba T, Takano K, Suzuki T, Kami M, Takita M, et al. A case of exacerbation of subclinical hyperthyroidism after first administration of BNT162b2 mRNA COVID-19 vaccine. Vaccines (Basel). 2021;9(10):1108. https:\/\/doi.org\/10.3390\/vaccines9101108.","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"1210_CR45","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.2169\/internalmedicine","volume":"61","author":"M Sakai","year":"2022","unstructured":"Sakai M, Takao K, Kato T, Ito K, Kubota S, Hirose T, et al. Graves\u2019 disease after administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in a type 1 diabetes patient. Intern Med. 2022;61(10):1561\u20135. https:\/\/doi.org\/10.2169\/internalmedicine.","journal-title":"Intern Med"},{"issue":"4","key":"1210_CR46","doi-asserted-by":"publisher","first-page":"e220049","DOI":"10.1530\/ETJ-22-0049","volume":"11","author":"R Manta","year":"2022","unstructured":"Manta R, Martin C, Muls V, Poppe KG. New-onset Graves\u2019 disease following SARS-CoV-2 vaccination: a case report. Eur Thyroid J. 2022;11(4):e220049. https:\/\/doi.org\/10.1530\/ETJ-22-0049.","journal-title":"Eur Thyroid J"},{"issue":"4","key":"1210_CR47","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ando.2022.04.014","volume":"83","author":"F Bres","year":"2022","unstructured":"Bres F, Joyeux MA, Delemer B, Vitellius G, Barraud S. Three cases of thyroiditis after COVID-19 RNA-vaccine. Ann Endocrinol (Paris). 2022;83(4):262\u20134. https:\/\/doi.org\/10.1016\/j.ando.2022.04.014.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"7","key":"1210_CR48","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.26355\/eurrev_202204_28500","volume":"26","author":"A Taieb","year":"2022","unstructured":"Taieb A, Sawsen N, Asma BA, Ghada S, Hamza E, Yosra H, et al. A rare case of grave\u2019s disease after SARS-CoV-2 vaccine: is it an adjuvant effect? Eur Rev Med Pharmacol Sci. 2022;26(7):2627\u201330. https:\/\/doi.org\/10.26355\/eurrev_202204_28500.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"1210_CR49","doi-asserted-by":"publisher","first-page":"e24418","DOI":"10.7759\/cureus.24418","volume":"14","author":"G Singh","year":"2022","unstructured":"Singh G, Howland T. Graves\u2019 disease following COVID-19 vaccination. Cureus. 2022;14(4):e24418. https:\/\/doi.org\/10.7759\/cureus.24418.","journal-title":"Cureus"},{"issue":"12","key":"1210_CR50","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s40618-022-01863-x","volume":"45","author":"RM Ruggeri","year":"2022","unstructured":"Ruggeri RM, Giovanellla L, Campenni A. SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature. J Endocrinol Invest. 2022;45(12):2283\u20139. https:\/\/doi.org\/10.1007\/s40618-022-01863-x.","journal-title":"J Endocrinol Invest"},{"key":"1210_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11050934","author":"F Nakamura","year":"2023","unstructured":"Nakamura F, Awaya T, Ohira M, Enomoto Y, Moroi M, Nakamura M. Graves\u2019 disease after mRNA COVID-19 vaccination, with the presence of autoimmune antibodies even one year later. Vaccines (Basel). 2023. https:\/\/doi.org\/10.3390\/vaccines11050934.","journal-title":"Vaccines (Basel)"},{"issue":"19","key":"1210_CR52","doi-asserted-by":"publisher","first-page":"11492","DOI":"10.3390\/ijms231911492","volume":"23","author":"G Lioulios","year":"2022","unstructured":"Lioulios G, Tsouchnikas I, Dimitriadis C, Giamalis P, Pella E, Christodoulou M, et al. Two cases of autoimmune thyroid disorders after COVID vaccination in dialysis patients. Int J Mol Sci. 2022;23(19):11492. https:\/\/doi.org\/10.3390\/ijms231911492.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1210_CR53","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12902-023-01287-5","volume":"23","author":"S Yasuda","year":"2023","unstructured":"Yasuda S, Suzuki S, Yanagisawa S, Morita H, Haisa A, Satomura A, et al. HLA typing of patients who developed subacute thyroiditis and Graves\u2019 disease after SARS-CoV-2 vaccination: a case report. BMC Endocr Disord. 2023;23(1):54. https:\/\/doi.org\/10.1186\/s12902-023-01287-5.","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"1210_CR54","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2174\/1871530322666220616104058","volume":"23","author":"I Taskaldiran","year":"2023","unstructured":"Taskaldiran I, Altay FP, Bozkus Y, Iyidir OT, Nar A, Tutuncu NB. A case report of conversion from Hashimoto\u2019s thyroiditis to Graves\u2019 disease in type 1 diabetic patient following the COVID-19 vaccination. Endocr Metab Immune Disord Drug Targets. 2023;23(3):405\u20139. https:\/\/doi.org\/10.2174\/1871530322666220616104058.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"9","key":"1210_CR55","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.jfma.2022.02.010","volume":"121","author":"SR Shih","year":"2022","unstructured":"Shih SR, Wang CY. SARS-CoV-2 vaccination related hyperthyroidism of Graves\u2019 disease. J Formos Med Assoc. 2022;121(9):1881\u20132. https:\/\/doi.org\/10.1016\/j.jfma.2022.02.010.","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"1210_CR56","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s12020-021-02902-y","volume":"74","author":"C Sriphrapradang","year":"2021","unstructured":"Sriphrapradang C, Shantavasinkul PC. Graves\u2019 disease following SARS-CoV-2 vaccination. Endocrine. 2021;74(3):473\u20134. https:\/\/doi.org\/10.1007\/s12020-021-02902-y.","journal-title":"Endocrine"},{"issue":"3","key":"1210_CR57","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12020-021-02898-5","volume":"74","author":"KA Lee","year":"2021","unstructured":"Lee KA, Kim YJ, Jin HY. Thyrotoxicosis after COVID-19 vaccination: seven case reports and a literature review. Endocrine. 2021;74(3):470\u20132. https:\/\/doi.org\/10.1007\/s12020-021-02898-5.","journal-title":"Endocrine"},{"issue":"1","key":"1210_CR58","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12020-021-02919-3","volume":"75","author":"L Di Filippo","year":"2022","unstructured":"Di Filippo L, Castellino L, Giustina A. Occurrence and response to treatment of Graves\u2019 disease after COVID vaccination in two male patients. Endocrine. 2022;75(1):19\u201321. https:\/\/doi.org\/10.1007\/s12020-021-02919-3.","journal-title":"Endocrine"},{"issue":"4","key":"1210_CR59","doi-asserted-by":"publisher","first-page":"e1767","DOI":"10.1210\/clinem\/dgab822","volume":"107","author":"LM Raven","year":"2022","unstructured":"Raven LM, McCormack AI, Greenfield JR, et al. Three cases of subacute thyroiditis following SARS-CoV-2 vaccine. J Clin Endocrinol Metab. 2022;107(4):e1767\u20138. https:\/\/doi.org\/10.1210\/clinem\/dgab822.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1210_CR60","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1507\/endocrj.EJ22-0208","volume":"69","author":"S Chaudhary","year":"2022","unstructured":"Chaudhary S, Dogra V, Walia R. Four cases of Graves\u2019 disease following viral vector severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) vaccine. Endocr J. 2022;69(12):1431\u20135. https:\/\/doi.org\/10.1507\/endocrj.EJ22-0208.","journal-title":"Endocr J"},{"issue":"4","key":"1210_CR61","doi-asserted-by":"publisher","first-page":"003275","DOI":"10.12890\/2022_003275","volume":"9","author":"D Cuenca","year":"2022","unstructured":"Cuenca D, Aguilar-Soto M, Mercado M. A case of Graves\u2019 disease following vaccination with the Oxford-AstraZeneca SARS-CoV-2 vaccine: case report and review of the literature. Eur J Case Rep Intern Med. 2022;9(4):003275. https:\/\/doi.org\/10.12890\/2022_003275.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"9","key":"1210_CR62","doi-asserted-by":"publisher","first-page":"002807","DOI":"10.12890\/2021_002807","volume":"8","author":"G Pierman","year":"2021","unstructured":"Pierman G, Delgrange E, Jonas C. Recurrence of Graves\u2019 disease (a Th1-type Cytokine Disease) following SARS-CoV-2 mRNA vaccine administration: a simple coincidence? Eur J Case Rep Intern Med. 2021;8(9):002807. https:\/\/doi.org\/10.12890\/2021_002807.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"5","key":"1210_CR63","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.12998\/wjcc.v11.i5.1122","volume":"11","author":"BC Yan","year":"2023","unstructured":"Yan BC, Luo RR. Thyrotoxicosis in patients with a history of Graves\u2019 disease after SARS-CoV-2 vaccination (adenovirus vector vaccine): two case reports. World J Clin Cases. 2023;11(5):1122\u20138. https:\/\/doi.org\/10.12998\/wjcc.v11.i5.1122.","journal-title":"World J Clin Cases"},{"issue":"2","key":"1210_CR64","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12020-021-02879-8","volume":"74","author":"C Sriphrapradang","year":"2021","unstructured":"Sriphrapradang C. Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves\u2019 disease. Endocrine. 2021;74(2):226\u20137. https:\/\/doi.org\/10.1007\/s12020-021-02879-8.","journal-title":"Endocrine"},{"issue":"1","key":"1210_CR65","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1210\/clinem\/dgac550","volume":"108","author":"L Filippo","year":"2022","unstructured":"Filippo L, Castellino L, Allora A, Frara S, Lanzi R, Perticone F, et al. Distinct clinical features of post-COVID-19 vaccination early-onset Graves\u2019 disease. J Clin Endocrinol Metab. 2022;108(1):107\u201313. https:\/\/doi.org\/10.1210\/clinem\/dgac550.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1210_CR66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3803\/EnM.2019.34.1.29","volume":"34","author":"WM Wiersinga","year":"2019","unstructured":"Wiersinga WM. Graves\u2019 disease: can it be cured? Endocrinol Metab (Seoul). 2019;34(1):29\u201338. https:\/\/doi.org\/10.3803\/EnM.2019.34.1.29.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"Suppl 3","key":"1210_CR67","doi-asserted-by":"publisher","first-page":"S431","DOI":"10.33549\/physiolres.934018","volume":"67","author":"D Vejrazkova","year":"2018","unstructured":"Vejrazkova D, Vcelak J, Vaclavikova E, Vankova M, Zajickova K, Duskova M, et al. Genetic predictors of the development and recurrence of Graves\u2019 disease. Physiol Res. 2018;67(Suppl 3):S431\u20139. https:\/\/doi.org\/10.33549\/physiolres.934018.","journal-title":"Physiol Res"},{"issue":"1","key":"1210_CR68","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1530\/EJE-16-0725","volume":"176","author":"T Struja","year":"2017","unstructured":"Struja T, Fehlberg H, Kutz A, Guebelin L, Degen C, Mueller B, et al. Can we predict relapse in Graves\u2019 disease? Results from a systematic review and meta-analysis. Eur J Endocrinol. 2017;176(1):87\u201397. https:\/\/doi.org\/10.1530\/EJE-16-0725.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1210_CR69","doi-asserted-by":"publisher","first-page":"105951","DOI":"10.1016\/j.ijantimicag.2020.105951","volume":"55","author":"H Li","year":"2020","unstructured":"Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020;55(5):105951. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105951.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"1210_CR70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40779-020-00240-0","volume":"7","author":"YR Guo","year":"2020","unstructured":"Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11. https:\/\/doi.org\/10.1186\/s40779-020-00240-0.","journal-title":"Mil Med Res"},{"issue":"1","key":"1210_CR71","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10123-020-00152-y","volume":"24","author":"Y Araf","year":"2021","unstructured":"Araf Y, Faruqui NA, Anwar S, Hosen MJ. SARS-CoV-2: a new dimension to our understanding of coronaviruses. Int Microbiol. 2021;24(1):19\u201324. https:\/\/doi.org\/10.1007\/s10123-020-00152-y.","journal-title":"Int Microbiol"},{"issue":"6","key":"1210_CR72","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","volume":"198","author":"F Scialo","year":"2020","unstructured":"Scialo F, Daniele A, Amato F, Pastore L, Matera MG, Cazzola M, et al. ACE2: the major cell entry receptor for SARS-CoV-2. Lung. 2020;198(6):867\u201377. https:\/\/doi.org\/10.1007\/s00408-020-00408-4.","journal-title":"Lung"},{"issue":"1","key":"1210_CR73","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jhep.2020.09.031","volume":"74","author":"T Asselah","year":"2021","unstructured":"Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF. COVID-19: discovery, diagnostics and drug development. J Hepatol. 2021;74(1):168\u201384. https:\/\/doi.org\/10.1016\/j.jhep.2020.09.031.","journal-title":"J Hepatol"},{"issue":"1","key":"1210_CR74","doi-asserted-by":"publisher","first-page":"e3078","DOI":"10.1002\/btpr.3078","volume":"37","author":"BC Behera","year":"2021","unstructured":"Behera BC, Mishra RR, Thatoi H. Recent biotechnological tools for diagnosis of corona virus disease: a review. Biotechnol Prog. 2021;37(1):e3078. https:\/\/doi.org\/10.1002\/btpr.3078.","journal-title":"Biotechnol Prog"},{"issue":"4","key":"1210_CR75","doi-asserted-by":"publisher","first-page":"e00028","DOI":"10.1128\/CMR.00028-20","volume":"33","author":"K Dhama","year":"2020","unstructured":"Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus disease 2019-COVID-19. Clin Microbiol Rev. 2020;33(4):e00028-e120. https:\/\/doi.org\/10.1128\/CMR.00028-20.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"1210_CR76","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","volume":"27","author":"A Wu","year":"2020","unstructured":"Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27(3):325\u20138. https:\/\/doi.org\/10.1016\/j.chom.2020.02.001.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"1210_CR77","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/vaccines10040608","volume":"10","author":"L Soraci","year":"2022","unstructured":"Soraci L, Lattanzio F, Soraci G, Gambuzza ME, Pulvirenti C, Cozza A, et al. COVID-19 vaccines: current and future perspectives. Vaccines (Basel). 2022;10(4):608. https:\/\/doi.org\/10.3390\/vaccines10040608.","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"1210_CR78","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/molbev\/msaa231","volume":"38","author":"ET Prates","year":"2021","unstructured":"Prates ET, Garvin MR, Pavicic M, Jones P, Shah M, Demerdash O, et al. Potential pathogenicity determinants identified from structural proteomics of SARS-CoV and SARS-CoV-2. Mol Biol Evol. 2021;38(2):702\u201315. https:\/\/doi.org\/10.1093\/molbev\/msaa231.","journal-title":"Mol Biol Evol"},{"issue":"5742","key":"1210_CR79","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","volume":"309","author":"F Li","year":"2005","unstructured":"Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005;309(5742):1864\u20138. https:\/\/doi.org\/10.1126\/science.1116480.","journal-title":"Science"},{"issue":"5","key":"1210_CR80","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","volume":"176","author":"AC Walls","year":"2019","unstructured":"Walls AC, Xiong X, Park YJ, Tortorici MA, Snijder J, Quispe J, et al. Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell. 2019;176(5):1026-39.e15. https:\/\/doi.org\/10.1016\/j.cell.2018.12.028.","journal-title":"Cell"},{"issue":"6483","key":"1210_CR81","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260\u20133.","journal-title":"Science"},{"issue":"1","key":"1210_CR82","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.abb2507","volume":"3","author":"F Li","year":"2016","unstructured":"Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3(1):237\u201361. https:\/\/doi.org\/10.1126\/science.abb2507.","journal-title":"Annu Rev Virol"},{"issue":"2","key":"1210_CR83","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","volume":"21","author":"L Dai","year":"2021","unstructured":"Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat Rev Immunol. 2021;21(2):73\u201382. https:\/\/doi.org\/10.1038\/s41577-020-00480-0.","journal-title":"Nat Rev Immunol"},{"key":"1210_CR84","doi-asserted-by":"publisher","first-page":"617089","DOI":"10.3389\/fimmu.2020.617089","volume":"11","author":"A Vojdani","year":"2020","unstructured":"Vojdani A, Vojdani E, Kharrazian D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol. 2020;11:617089. https:\/\/doi.org\/10.3389\/fimmu.2020.617089.","journal-title":"Front Immunol"},{"issue":"9","key":"1210_CR85","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/vaccines10091445","volume":"10","author":"A Patrizio","year":"2022","unstructured":"Patrizio A, Ferrari SM, Elia G, Ragusa F, Paparo SR, Mazzi V, et al. Graves\u2019 disease following SARS-CoV-2 vaccination: a systematic review. Vaccines (Basel). 2022;10(9):1445. https:\/\/doi.org\/10.3390\/vaccines10091445.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"1210_CR86","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","volume":"36","author":"Y Shoenfeld","year":"2011","unstructured":"Shoenfeld Y, Agmon-Levin N. \u201cASIA\u201d - autoimmune\/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36(1):4\u20138. https:\/\/doi.org\/10.1016\/j.jaut.2010.07.003.","journal-title":"J Autoimmun"},{"issue":"2\u20133","key":"1210_CR87","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12026-014-8586-0","volume":"60","author":"S Esposito","year":"2014","unstructured":"Esposito S, Prada E, Mastrolia MV, Tarantino G, Codeca C, Rigante D. Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the Pediatric background. Immunol Res. 2014;60(2\u20133):366\u201375. https:\/\/doi.org\/10.1007\/s12026-014-8586-0.","journal-title":"Immunol Res"},{"key":"1210_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2013.10.004","volume":"47","author":"C Perricone","year":"2013","unstructured":"Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun. 2013;47:1\u201316. https:\/\/doi.org\/10.1016\/j.jaut.2013.10.004.","journal-title":"J Autoimmun"},{"issue":"1","key":"1210_CR89","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1186\/s13063-020-04775-4","volume":"21","author":"R Palacios","year":"2020","unstructured":"Palacios R, Patino EG, de Oliveira PR, Conde M, Batista AP, Zeng G, et al. Double-blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (Inactivated) vaccine manufactured by Sinovac\u2014PROFISCOV: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):853. https:\/\/doi.org\/10.1186\/s13063-020-04775-4.","journal-title":"Trials"},{"issue":"4","key":"1210_CR90","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","volume":"53","author":"D Laczko","year":"2020","unstructured":"Laczko D, Hogan MJ, Toulmin SA, Hicks P, Lederer K, Gaudette BT, et al. A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in Mice. Immunity. 2020;53(4):724-32e7. https:\/\/doi.org\/10.1016\/j.immuni.2020.07.019.","journal-title":"Immunity"},{"issue":"20","key":"1210_CR91","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","volume":"383","author":"LA Jackson","year":"2020","unstructured":"Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA vaccine against SARS-CoV-2\u2014preliminary report. N Engl J Med. 2020;383(20):1920\u201331. https:\/\/doi.org\/10.1056\/NEJMoa2022483.","journal-title":"N Engl J Med"},{"issue":"12","key":"1210_CR92","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","volume":"54","author":"MG Alameh","year":"2021","unstructured":"Alameh MG, Tombacz I, Bettini E, Lederer K, Sittplangkoon C, Wilmore JR, et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity. 2021;54(12):2877-92.e7. https:\/\/doi.org\/10.1016\/j.immuni.2021.11.001.","journal-title":"Immunity"},{"key":"1210_CR93","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.copbio.2021.09.016","volume":"73","author":"E Kon","year":"2022","unstructured":"Kon E, Elia U, Peer D. Principles for designing an optimal mRNA lipid nanoparticle vaccine. Curr Opin Biotechnol. 2022;73:329\u201336. https:\/\/doi.org\/10.1016\/j.copbio.2021.09.016.","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"1210_CR94","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/j.bja.2020.12.020","volume":"126","author":"LH Garvey","year":"2021","unstructured":"Garvey LH, Nasser S. Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit? Br J Anaesth. 2021;126(3):e106\u20138. https:\/\/doi.org\/10.1016\/j.bja.2020.12.020.","journal-title":"Br J Anaesth"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01210-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01210-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01210-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T07:03:45Z","timestamp":1689231825000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01210-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1210"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01210-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"assertion":[{"value":"8 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}